TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06026540

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilates Exercise
Description: After the first measurements were made and the groups were determined; Students in the experimental group will be given pilates exercises 2 days a week for 6 months. Pilates mat, pilates circle, tiny pilates ball and pilates band will be used during the pilates exercise. The duration of the Pilates exercise is 30 minutes in total, and the peer-guided application via Zoom includes the following order:~Stretching 5 minutes, superman 1 minute, quodratus stretch 2 minutes, marble 1 minute, half plank kick 4 minutes, side kick 4 minutes, pelvic curl 2 minutes, cat pose 1 minute, spine stretch 2 minutes, one leg circle 3 minutes, side leg lift 3 minutes, single leg kick 2 minutes.
Study: NCT06020391

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collaborative drug review
Description: 1. Structured, clinical drug review including medical history, physical examination, and supplementary tests. The work-up will be aimed at evaluating whether current medications are indicated, whether the patient's medical conditions are satisfactorily compensated, whether dosages are appropriate, whether the patient has adverse drug effects, and whether drug-drug or drug-disease interactions are present or likely to occur. The MipAC physicians will receive clinical supervision from a consultant in geriatric medicine.~2. The MipAC physician will offer the patient's FP a telephone meeting with the purpose of combining the assessments of the MipAC physician and the competence of the FP in a common drug review. The two physicians will review the patient's drug list systematically and discuss if any adjustments should be done, as well as the patient's need for further follow-up.
Study: NCT04891718

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVC-101
Description: Intratumoural microdose injection by the CIVO device.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Intratumoural microdose injection by the CIVO device.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: MVC-101 + Nivolumab
Description: Intratumoural microdose injection by the CIVO device.
Study: NCT05170958

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBL-024 for Injection
Description: LBL-024 was given every three weeks for treatment
Study: NCT04887168

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Survive & Thrive
Description: Psychoeducational Intervention: Survive \& Thrive (Ferguson, 2008; Mahoney et al, 2018). A total of 10 manualised sessions of approximately 1.5 hour duration are offered. Individual sessions run using an educational format and in an informal setting, with a strong emphasis on avoiding individual disclosures. Groups will be delivered utilising a multi-disciplinary work force consisting of mental health staff in a ratio of 2 per group. Groups will consist of a maximum of 8-10 participants
Study: NCT05728424

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vonoprazan, Amoxicillin, Levofloxacin
Description: No additional information

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vonoprazan, Amoxicillin, Levofloxacin
Description: No additional information
Study: NCT05544214

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-371
Description: PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-371
Description: PO
Study: NCT06124495

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
Description: The subjects randomly received single oral dose of Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet (Test or reference)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
Description: The subjects randomly received single oral dose of Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet (Test or reference)
Study: NCT04946682

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Types of etiological diagnostic methods
Description: In Group of mNGS, all patients will be tested by meta next generation sequncing on admission, while patients in Group of PCR will be tested by polymerase chain reaction in accordance with the method in the guidelines.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Types of etiological diagnostic methods
Description: In Group of mNGS, all patients will be tested by meta next generation sequncing on admission, while patients in Group of PCR will be tested by polymerase chain reaction in accordance with the method in the guidelines.
Study: NCT05906485

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: fNIRS Neurofeedback-VR Training
Description: In the fNIRS Neurofeedback-VR Training, we have designed a classroom scenario modeled and children are expected to learn how to regulate their attention based on the feedback provided by the fNIRS on the oxygenated haemoglobin level in their prefrontal cortex.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: fNIRS Neurofeedback-VR Training
Description: In the fNIRS Neurofeedback-VR Training, we have designed a classroom scenario modeled and children are expected to learn how to regulate their attention based on the feedback provided by the fNIRS on the oxygenated haemoglobin level in their prefrontal cortex.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Computerized Cognitive Training
Description: In the Computerized Cognitive Training, children will complete a range of tasks covering attention control and working memory using a conventional training programme, namely Cogmed.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Computerized Cognitive Training
Description: In the Computerized Cognitive Training, children will complete a range of tasks covering attention control and working memory using a conventional training programme, namely Cogmed.
Study: NCT06354920

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bonding Bundle
Description: Doctors in the intervention arm will be asked to use suggested approaches while meeting with their hospitalized patients. The goal of these strategies is to improve the relationship and interactions between patients and physicians.
Study: NCT06237660

Intervention type: DIAGNOSTIC_TEST
Intervention: Finger prick blood test
Description: Finger prick testing will be used for blood samples, and it is the same technique used by children with diabetes, to test their blood sugar levels, and therefore is regularly used in this age group successfully. The research team will be obtain the results within minutes, using a point-of-care device. A few more drops of blood, from the same finger prick sample, will be taken to look at how one of the blood cells work, in more detail, in the laboratory. There is no additional finger prick required for this lab test, and the drops of blood will be collected at the same time, from the same prick, as the point of care test.
Study: NCT06458179

Intervention type: PROCEDURE
Intervention: Ultrasound-guided proximal greater occipital nerve radiofrequency ablation
Description: In the prone position with the head slightly flexed and the US probe was placed in the neck transversely and then was located the bifid spinous process of C2 and the probe was lateralized (toward the affected side). At this level, the GON is located above the obliquus capitis inferior muscle and deeper than the semispinalis capitis muscle. The in-plane approach from medial to lateral was employed to treat the nerve with a 21 G 5-mm active tip radiofrequency needle. Sensory stimulation was administered at 50 Hz for 1 ms to induce paresthesia, pain, or irritation. A motor stimulus was applied at 2 Hz for 1 ms and up to 2 volts to see if fasciculation was absent. Then 1 mL of 2% lidocaine was administered through the RF cannulas to alleviate procedure related pain. Conventional RFA was conducted for 60 seconds at a temperature of 60 degrees. Following the procedure, 2 mg of dexamethasone was administered per lesion site.
Study: NCT04752072

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Skills Training in Affective and Interpersonal Regulation
Description: The first (formulation) session enables linking present difficulties and traumatic events, identifying current issues/concerns, and collaboratively agreeing on the order of modules based on symptom severity and client readiness.~The PTSD module provides narrative exposure to the traumatic memories and targets re-experiencing, avoidance and hyperarousal symptoms. The AD module focuses on identifying and labelling feelings, emotion management, distress tolerance, acceptance of feelings and experiencing positive emotions. The NSC module focuses on staying in the present moment and combating dissociation; self-compassion and mindfulness skills; challenging thinking patterns and developing a balanced view of self. The DR module focuses on exploring and revising maladaptive schemas; effective assertiveness; awareness of social context; and flexibility in interpersonal expectations and behaviours displayed in social interactions.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: The first session will involve a mental health assessment by either a psychiatrist or psychologist. A treatment package will be developed based on the information collected during the assessment. Details of the interventions delivered to each participant receiving TAU, which will include elements of psychoeducation, symptom-management and trauma-focused cognitive behaviour therapy, will be recorded.
Study: NCT05268900

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Volume control ventilation group
Description: Volume control ventilation mode
Study: NCT05812443

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shabad Kriya Meditation
Description: The Shabad Krya meditation technique, used in Kundalini Yoga, will be performed by the participants of this intervention group for 8 consecutive weeks, for 30 minutes, before going to sleep. This group will be trained by a Kundalini Yoga teacher with extensive experience in Shabad Krya meditation. The evaluation of Sleep Quality, Mental Health and Spirituality parameters will be measured through specific questionnaires, shortly after the end of the eighth week of intervention, and also one month and three months after the end of the intervention.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Relaxing reading
Description: Relaxing reading will be performed by the participants of this control group for 8 consecutive weeks, for 30 minutes, before going to sleep. The evaluation of Sleep Quality, Mental Health and Spirituality parameters will be measured through specific questionnaires, shortly after the end of the eighth week of intervention, and also one month and three months after the end of the intervention.
Study: NCT04839692

Intervention type: DRUG
Group type: OTHER
Intervention: Hyaluronic acid filler
Description: Hyaluronic acid filler treatment of the lips with Restylane Kysse, which is a FDA approved treatment for lip augmentation.

Intervention type: DRUG
Group type: OTHER
Intervention: Hyaluronic acid filler
Description: Hyaluronic acid filler treatment of the lips with Restylane Kysse, which is a FDA approved treatment for lip augmentation.
Study: NCT05180357

Intervention type: OTHER
Intervention: FASENRA(benralizumab)
Description: This is a retrospective, observational study with secondary data collection utilizing medical chart review in hospitals or clinical centres that treated SEA + NP patients with benralizumab. Patient data including demographics, clinical characteristics, medication history, biologic treatment, and NP and asthma clinical outcomes will be abstracted from patient medical charts onto a pre-approved electronic case report form. No personal identifiable data will be collected. Data from all participating centres will be combined into a single anonymised dataset for analysis.
Study: NCT05713981

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Meibomian gland (MG) expression
Description: The procedure is performed with a sterile cotton tip applicator once in the upper and lower eyelids of the subject's choosing.
Study: NCT05962684

Intervention type: OTHER
Intervention: ERAS
Description: Implementation of ERAS protocol in elective craniotomy patients
Study: NCT05684445

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Distant reiki group
Description: According to Classical Usui Reiki, Reiki II. Remote Reiki will be practiced every day for 10 days by researchers who have completed the Phase 1 training. The time of remote reiki application will be planned by talking with the patient.
Study: NCT05268900

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pressure control ventilation-volume guaranteed group
Description: Pressure control ventilation-volume guaranteed mode
Study: NCT05612893

Intervention type: OTHER
Intervention: pathogen
Description: The patients were divided into groups according to the pathogen(bacteria or virus).~The influenza upper respiratory tract infection cohort will be grouped mainly according to age.

Intervention type: OTHER
Intervention: pathogen
Description: The patients were divided into groups according to the pathogen(bacteria or virus).~The influenza upper respiratory tract infection cohort will be grouped mainly according to age.
Study: NCT05074160

Intervention type: DEVICE
Intervention: OCS Liver
Description: Multi-center, observational post-approval registry of adult primary liver transplant recipients who are transplanted with an OCS Liver-perfused DBD or DCD donor liver according to the approved indication and that match the eligibility criteria below.
Study: NCT04939909

Intervention type: DRUG
Group type: OTHER
Intervention: Botulinum toxin type A
Description: Patients were treated with Botulinum toxin type A applications on the Orbicularis oculi and glabellar complex
Study: NCT05083962

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Lifestyle Program
Description: An intensive behavior change curriculum designed to help create and sustain healthy habits
Study: NCT05521386

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caffeine
Description: Single pill in an acute dose of 5 mg per kg of body mass

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single pill in an acute dose of 5 mg per kg of body mass
Study: NCT04759833

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prucalopride
Description: Prucalopride oral solution or oral tablets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prucalopride
Description: Prucalopride oral solution or oral tablets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prucalopride
Description: Prucalopride oral solution or oral tablets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prucalopride
Description: Prucalopride oral solution or oral tablets.
Study: NCT04901390

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Yogurt with B. lactis and added cane sugar
Description: The intervention condition will utilize a commercially available yogurt (Activia) that contains Bifidobacterium animalis lactis DN-173 010/CNCM I-2494 (B. lactis). Participants will consume 170 g of yogurt with cane sugar twice daily for 14 days.
Study: NCT05612893

Intervention type: OTHER
Intervention: pathogen
Description: The patients were divided into groups according to the pathogen(bacteria or virus).~The influenza upper respiratory tract infection cohort will be grouped mainly according to age.
Study: NCT05860257

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PeerLearning.net
Description: PeerLearning.net provides an easy-to-use, scalable, and widely accessible means to support teachers in effectively designing and delivering high-fidelity Cooperative Learning (CL) lessons and, in turn, it has the potential to amplify the positive effects of CL found in previous research. Using PeerLearning.net, teachers design their lesson by selecting from among a set of typical CL lesson templates (e.g., jigsaw, peer tutoring, group projects) which they can customize and populate with their own curriculum and materials. These design templates represent the optimal, high-fidelity design that is required in order for CL to be successful. During lesson delivery, PeerLearning.net manages membership in learning groups, distributes instructional materials, directs student activities according to a pre-specified timetable, supports teacher observations of student behavior, and delivers post-lesson group activities and reviews.
Study: NCT06106581

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VLA1553 full dose
Description: Single intramuscular vaccination on Day 1 with VLA1553 full dose, a lyophilized live-attenuated Chikungunya vaccine candidate

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VLA1553 half dose
Description: Single intramuscular vaccination on Day 1 with VLA1553 half dose, a lyophilized live-attenuated Chikungunya vaccine candidate

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Nimenrix
Study: NCT06326359

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: autologous stromal vascular fraction
Description: autologous stromal vascular fraction injection as 2 sessions with 1 month interval at arm 1 arm 2: will receive 2 sessions of PRP with 3 weeks interval followed by stromal vascular fraction injection as 2 sessions with 1 month interval

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: autologous stromal vascular fraction
Description: autologous stromal vascular fraction injection as 2 sessions with 1 month interval at arm 1 arm 2: will receive 2 sessions of PRP with 3 weeks interval followed by stromal vascular fraction injection as 2 sessions with 1 month interval
Study: NCT05192616

Intervention type: DEVICE
Intervention: Covered stent implantation
Description: Percutaneous transluminal angioplasty (PTA) with iCover covered stent for the treatment of de novo aorto-iliac occlusive lesions
Study: NCT04759833

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Prucalopride-matching placebo oral solution or oral tablets.
Study: NCT04610320

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab-SC
Description: \>Daratumumab-SC 1800 mg subcutaneous weekly for 8 doses and then every other week for 2 doses.
Study: NCT06049706

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active Priming
Description: It will be applied an active priming stimulation in the supplementary motor area previously to the main stimulation to analyse if that will enhance the response to TMSr, compared to inactive priming.~To apply intervention, it will be used Repetitive Transcranial Magnetic Stimulation Model MagPro R20 (MagVenture Brazil, country Brazil) and the butterfly coil MCF-B70 (MagVenture Brazil, country Brazil).~Each session will last around 20 minutes, and it will be used a 1 Hz frequency, 1200 pulses/day, with 100% of Motor Threshold, once a day, 5 days a week, for two consecutive weeks.~Active Priming group participants will be previously stimulated for 10 minutes (20 trains of 5 seconds with intertrain interval of 25 seconds), with 6Hz frequency over Supplementary Motor Area, receiving 80% of Motor Threshold, with a total of 600 stimulations.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Priming
Description: Sham Priming group participants will receive a placebo stimulation for ten minutes, with the same parameters and target area as the active group, they will hear the equipament noise and might feel any sensation in the scalp, but there won't be effective stimulation.
Study: NCT05533294

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARO-RAGE Injection
Description: ARO-RAGE injection for sc administration

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: normal saline (0.9% NaCl) by sc injection
Study: NCT05471492

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Investigational Product
Description: PF-06480605 150 mg

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05180916

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TVNS
Description: Cerbomed NEMOS
Study: NCT05303636

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet
Description: LF111 (drospirenone 4 mg tablet orally daily on days 1-24, followed by placebo tablet orally daily on days 25-28) or drospirenone (DRSP) 3.5 mg chewable tablet chewed daily on days 1-24, followed by placebo tablet chewed daily on days 25-28) (USA only). Subjects in the USA who choose to use the hormonal contraceptive method may choose between LF111 and DRSP 3.5 mg chewable tablets. The DRSP 3.5 mg chewable tablets are not available to subjects in Europe. Subjects in Europe who choose to use the hormonal contraceptive method will only receive LF111.
Study: NCT05753995

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: PET imaging
Description: The evaluation of PET imaging using PET ligand \[18F\]JNJ-64413739 or a \[18F\] labeled equivalent in vivo in patients.
Study: NCT06128889

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supporting Transition and Resilience to Clinical Nursing Education (STRONG) Program
Description: The STRONG program adopts an asynchronous online learning approach and will be delivered over one week by a trained counsellor, and a nurse researcher. Students will attend an online self-paced program. The program will comprise of topics such as: (1) Resilience and protective factors, (2) introduction to clinical nursing education, (3) experiences of clinical attachments, and (4) stress, physical wellbeing and diet materials. Students will have access to online materials (e.g., short videos), have opportunities to discuss (e.g., forum) and infographics. Overall, the program will be delivered over in one week lasting six hours.
Study: NCT06053151

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise counselling
Description: . The experimental group will receive the cloud platform integration model for exercise consultation intervention for two phases continue 24 weeks to promote exercise behavior during pregnancy. The goal of the first phase was to start regular exercise, and the goal of the second phase was to continue regular exercise.